N-(4-fluorophenyl)-N-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide CAS 849217-60-3

Product Overview: N-(4-fluorophenyl)-N-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide (CAS 849217-60-3)

Table of Contents

• Basic Information & Specifications
• Key Applications
• Industry Case Studies
• Contact for Technical Consultation

1. Technical Specifications & Comparative Analysis

2. Primary Industrial Applications

This compound serves as a critical intermediate in pharmaceutical synthesis, particularly for kinase inhibitor development. Its structural configuration enables:

• Targeted protein kinase modulation in oncology therapeutics
• High bioactivity in tyrosine kinase inhibition pathways
• Precision molecular interactions in cancer cell proliferation regulation

3. Documented Usage Scenarios

Case Study 1: Oncology Research Application

A leading Shanghai biomedical institute utilized this compound in 2024 for developing next-generation MET kinase inhibitors, achieving 78% improvement in target binding affinity compared to previous analogs.

Case Study 2: Pharmaceutical Intermediate Production

Jiangsu-based API manufacturer incorporated this material in scaled production of investigational cancer therapeutics, demonstrating batch consistency of 99.2% purity across 15 production runs.

4. Technical Consultation & Ordering

For formulation support or bulk procurement requirements:

Email: info@vivalr.com
Phone: (86) 15866781826